About
Wellness
Investors
Contact
en

Rodrigo Gallardo

Interim CEO

Rodrigo Gallardo is an accomplished international business executive with three decades of experience in marketing, business development, and corporate strategy. A lawyer by training from UIA, he also holds certifications in Business Administration and Top Executive Management from IPADE.

As a co-founder of a boutique family law firm, Rodrigo has built a strong reputation in representing foreign companies in Mexico. His extensive entrepreneurial background spans the food, entertainment, construction, and real estate industries, where he has held key executive roles.

Rodrigo is also a pioneer in the Mexican cannabis industry. As the co-founder of Elements Bioscience and Sativa Group Biosciences, he played a pivotal role in their 2019 merger to form Xebra Brands Ltd., positioning the company as the first mover in Mexico’s cannabis sector. Under his leadership, Xebra secured a historic injunction from the Mexican Supreme Court, granting its subsidiary Desart MX unique cannabis rights, the first company in Mexican history to achieve this milestone. In October 2021, Rodrigo successfully led Xebra Brands Ltd. to go public on the Canadian Securities Exchange (CSE), further solidifying its position in the global cannabis market. In 2023, Xebra made further history by obtaining the first-ever cannabis authorization from COFEPRIS (Mexico’s FDA).

With a proven track record in navigating regulatory landscapes, taking companies public, building brands, and driving market innovation, Rodrigo continues to lead the charge in shaping the future of the cannabis industry in Mexico and beyond.

Omar Garcia Abrego

Chief Financial Officer & Corporate Secretary

Omar Garcia Abrego is a Canadian Chartered Professional Accountant (CPA, CA) with over 25 years of progressive international accounting experience within the public and private markets. Mr. Abrego possesses a demonstrated ability to streamline business processes, develop and implement financial controls to improve efficiency and accuracy of the financial information and is proficient in all technical aspects of accounting, financial reporting and regulatory filing compliance for public companies.

Mr. Abrego also has significant experience in business acquisition transactions and held multiple executive and senior positions in various companies such as Liberty Defense Holdings, Altaley Mining Corporation, Auryn Resources, Cayden Resources (which was sold to Agnico Eagle Mining Limited for $205 million in November 2014), Farallon Mining (which was also sold to Nyrstar NV for $409 million in January 2011), Graymont Limited and Deloitte LLP. Mr. Abrego holds a Bachelor of Public Accounting degree from Instituto Tecnológico y de Estudios Superiores de Monterrey and is also a Certified Public Accountant (CPC) in Mexico.

Keith Dolo

Director

Keith brings an impressive résumé and track record to the Board. He is the co-founder of Maverick Brands, a growth accelerator that has successfully built, scaled and exited multiple companies. Before Maverick, Keith founded and served as the CEO and Chairman of Sproutly Canada Inc., a company focused on the advancement of beverage formulations in the Canadian Cannabis Industry. Previous to Sproutly, Keith spent over 13 years at Robert Half International, an S&P 500 and NYSE-listed company where he held the role of VP and other senior positions. Keith advises/acts as director on multiple Canadian companies.

Erick Ponce

Director

Mr. Ponce is a businessman, investor, and founder and Executive Director of ICAN, a company focused on the medical cannabis market in Latin America and one of the few licensed to operate in Mexico. Erick is the president of GPIC (“Grupo Promotor de la Industria del Cannabis”), the leading cannabis business group in Mexico focused on lobbying and market intelligence, and is also the vice president of REDCANN, a network of cannabis associations throughout Latin America.

Erick actively participates in various international industry events to which he is often invited by private and government groups, most recently in countries such as Canada, Chile, Colombia, Ecuador, the United States, Peru, Uruguay, and Mexico.

David Ross Macias Diaz

Director

Mr Macias is a mexican entrepreneur and business man with a degree in business administration from the Anahuac University, his hard work life style took him in to the energy industry in which he has become one of the biggest fuel distributors in Mexico. Mr Macias plays a fundamental role in this industry.

David also participates in several business related to the hospitality sector, owning many restaurants and a top world wide ranked luxury hotel & spa in San Luis Potosi Mexico. His entreprenural spirit has led him to explore the cannabis industry, focusing in cultivation as he owns a 2,700 acre ranch in SLP in which he intends to cultivate industrial hemp. In 2023 Mr Macias joined Xebra as a large shareholder and in 2024 he became part of Xebra’s board bringing along his wide expertise and networking.

Xebra Brands Ltd. All Rights Reserved.

Legal Disclaimers

About
Wellness
Investors
Contact

Your Consent

Basically… if you give us your email address, you’re saying it’s OK to hear from us!

On our website you can contact us to ask questions, sign-up for updates, and be added to product waitlists. By doing so, you consent to receiving emails from us.

Privacy Policy

Bottom line… your personal information is precious!

Your personal data is private and confidential, and we take this very seriously. We will not sell your data, nor will we share your data with third-parties. If we use your personal information, it will be only for as you intended — to keep you informed.

Do We Use Cookies?

Cookies with milk, not websites!

If you allow it, many websites place small files (cookies) on your computer hard drive, to track and save your browser habits and preferences. We respect your privacy, hence we mainly wish to know and save your legal age and language preference — English or Spanish.

Warning

It’s common sense!

Consult your doctor before consuming cannabis products. Use of cannabis during pregnancy or while breastfeeding may be harmful. Keep cannabis products away from animals and out of the reach of children. Do not operate a vehicle or any kind of machinery after consumption of cannabis. Cannabis is still considered a Schedule 1 Controlled Substance in the United States. Possession, distribution, and cultivation of cannabis is still prohibited under US federal law.

Forward-Looking Statements

To put it simply… we have plans, but plans can change!

Certain information contained on this website, and in related presentations, fact sheets, and videos constitute forward-looking statements under applicable securities laws. Any statements that are not statements of historical fact may be deemed to be forward-looking statements, these include, without limitation, statements regarding Xebra Brands Ltd.’s (“XEBRA” or “XEBRA’S”) expectations in respect of its ability to successfully execute its business plan or business model; its ability to provide economic, environmental, social, or any benefits of any type, in the communities it operates in or may operate it in the future; its ability to be a first mover in a country, or to obtain or retain government licenses, permits or authorizations in general, or specifically in Mexico, Colombia, Canada, the Netherlands, or elsewhere; its ability to raise capital and fund its ongoing operations; its ability to list its shares on a stock exchange or attain a public listing, its ability to successfully apply for and obtain trademarks and other intellectual property in any jurisdiction; its ability to be cost competitive; its ability to cultivate, grow, or process hemp or cannabis in Mexico, Colombia, Canada, the Netherlands, or elsewhere; its ability to manufacture cannabis beverages, wellness products, or other products; its ability to commercialize or sell cannabis beverages, wellness products, or other products, in Mexico, Colombia, Canada, the Netherlands, or elsewhere; its ability to commercialize or to sell Vicious Citrus Lemonade in 2022 or at any time, in any jurisdiction; its ability to commercialize or to sell Elements wellness products in Mexico, in Colombia, or in any jurisdiction in 2022 or at any time; its ability to make cannabis beverages that taste good; its ability to create wellness products that have a therapeutic effect or benefit; plans for future growth and the direction of the business; financial projections including expected revenues, gross profits, costs, capital expenditures and EBITDA (which is a non-GAAP financial measure); plans to increase product volumes, the capacity of existing facilities, supplies from third party growers and contractors; expected growth of the cannabis industry generally; management’s expectations, beliefs and assumptions; events or developments that XEBRA expects to take place in the future; and general economic conditions. All statements, other than statements of historical facts, are forward-looking information and statements. The words “aim”, “believe”, “expect”, “anticipate”, “contemplate”, “target”, “intends”, “continue”, “plans”, “budget”, “estimate”, “may”, “will”, “projected”, and similar expressions identify forward-looking information and statements. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by XEBRA as of the dates of such statements, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Known and unknown factors could cause actual results to differ materially from those projected in the forward-looking statements. Such factors include, but are not limited to, the inability of XEBRA to generate sufficient revenues or to raise sufficient funds to carry out its business plan; the inability of Xebra to list its shares for trading on a stock exchange; changes in government legislation, taxation, controls, regulations and political or economic developments in various countries; risks associated with agriculture and cultivation activities generally, including inclement weather, access to supply of seeds, poor crop yields, and spoilage; compliance with import and export laws of various countries; significant fluctuations in cannabis prices and transportation costs; the risk of obtaining necessary licenses and permits; inability to identify, negotiate and complete a potential acquisition for any reason; the ability to retain key employees; dependence on third parties for services and supplies; non-performance by contractual counter-parties; general economic conditions; and the continued growth in global demand for cannabis products and the continued increase in jurisdictions legalizing cannabis; and the timely receipt of regulatory approval for license applications. The foregoing list is not exhaustive and XEBRA undertakes no obligation to update or revise any of the foregoing except as required by law. Many of these uncertainties and contingencies could affect XEBRA’s actual performance and cause its actual performance to differ materially from what has been expressed or implied in any forward-looking statements made by, or on behalf of, XEBRA. Readers are cautioned that forward-looking statements are not guarantees of future performance and readers should not place undue reliance on such forward-looking statements. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those set out in such statements.